9/16/2023 | 29349910 | HU/MS RECOM ACTIVIN A.100 UG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 1792.02 | CANADA | BANCOUVER |
9/16/2023 | 29349910 | HU RECOM BMP-4, 100 UG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 2988.76 | CANADA | BANCOUVER |
9/16/2023 | 29349910 | HU RECOM BFGF, ACF, 100 UG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 550.44 | CANADA | BANCOUVER |
9/16/2023 | 29349910 | Y-27632 (2HCL) 5MG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 470.04 | CANADA | BANCOUVER |
9/16/2023 | 29349910 | HU RECOM BETACELLULIN. 50 UG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 609.19 | CANADA | BANCOUVER |
9/16/2023 | 29349910 | CHIR99021.10 MG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 586 | CANADA | BANCOUVER |
9/16/2023 | 29349910 | COMPOUND E. 1 MG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 813.29 | CANADA | BANCOUVER |
9/16/2023 | 29349910 | HU RECOM FGF-7, ACF, 100 UG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 2577.47 | CANADA | BANCOUVER |
9/16/2023 | 29349910 | REPSOX.10 MG (FOR R&D USE) | XXXXXXXXXX | 2 | NOS | 347.89 | CANADA | BANCOUVER |